Eli Lilly (LLY) has agreed to acquire Adverum Biotechnologies (ADVM) including its lead product cand
PREMIUM
Upgrade to read this MT Newswires article and get so much more.
A Silver or Gold subscription plan is required to access premium news articles.
Upgrade
Already have a subscription? Sign in
Eli Lilly to Acquire Adverum Biotechnologies for Up to $12.47 a Share
Published 2 weeks ago
Oct 24, 2025 at 12:56 PM
Positive
Auto